drugset / Trial / NCT00514267
An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the feasibility and safety of administering YM155 in combination with docetaxel
Timeline
- Start
- 2007-05
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | — |
| Subject | SEPANTRONIUM | Small molecule | — | — |
| Background | Prednisone | Other / unclassified | — | Oral |